{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:29:42Z","timestamp":1794000582506,"version":"4.8.0"},"reference-count":55,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The present study aims to compare the monotherapy of diosmetin and 5-\nhydroxydecanoate (5-HD) against the therapeutic effect of their combination therapy in the unilaterally\ninjected rotenone-induced neurotoxicity in the male rats. Motor deficits accompany Parkinson's\nDisease (PD), while Bioflavonoids like diosmetin, which are antioxidants and anti-inflammatories,\nprotect against neurotoxins. Moreover, mitochondrial dysfunction contributes to PD. The\nmitochondrial ATP-sensitive potassium channel [mito(KATP)] regulates reactive species and 5-HD,\nmeaning decreasing it may lessen mitochondrial injury. To evaluate the effect of diosmetin, alone\nand in combination with 5-HD, on Oxidative Stress (OS) markers, mitochondrial function, and dopaminergic\npreservation in the SNpc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Male Wistar rats were divided into seven groups, including normal control, sham,\nrotenone-treated, and treatment groups receiving diosmetin, 5-HD, their combination, or selegiline\nas a standard drug. Biochemical assays were conducted to assess OS markers, mitochondrial complex-\nI activity, and dopaminergic neuroprotection. Behavioral tests were performed to evaluate\nmotor deficits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Rotenone administration significantly increased OS, impaired mitochondrial complex-I\nactivity, and reduced motor coordination. Diosmetin treatment significantly reverses the effects of\nrotenone. Combined treatment with diosmetin and 5-HD showed enhanced neuroprotective effects\ncompared to individual treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>This study demonstrates that both diosmetin and 5-HD monotherapies alleviate\nrotenone-induced behavioral impairments in the experimental rats. Additionally, the individual\ntreatment of diosmetin and 5-HD reduces dopaminergic toxicity induced by rotenone. At the sub--\ncellular level, diosmetin and 5-HD monotherapies counteract rotenone\u2019s impact on antioxidant\nmarkers, DA metabolites, and mitochondrial function in the SNpc region of the brain. Notably,\ncombining diosmetin and 5-HD yielded superior therapeutic effects on rotenone-induced behavioral\nand molecular changes compared to either monotherapy alone. These findings suggest that\ndiosmetin and 5-HD may offer a promising alternative for PD management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Diosmetin exhibits potent antioxidant and neuroprotective properties against\nrotenone-induced PD-like pathology. The combination of diosmetin and 5-HD offers a synergistic\ntherapeutic potential, suggesting a promising approach for managing oxidative stress and mitochondrial\ndysfunction in PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298665398088250904074136","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:00:20Z","timestamp":1761192020000},"page":"637-649","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of 5-Hydroxydecanoate in the Neuroprotective Activity of Diosmetin Against Rotenone-Induced Dopaminergic Toxicity in Rats"],"prefix":"10.2174","volume":"32","author":[{"given":"Krishna Kumar","family":"Varshney","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Chitkara University School ofPharmacy, Chitkara University, Baddi, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/mp.2013.3","volume":"19","author":"Drui G.","year":"2014","unstructured":"Drui G.; Carnicella S.; Carcenac C.; Favier M.; Bertrand A.; Boulet S.; Savasta M.; Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in parkinson\u2019s disease. Mol Psychiatry  2014,19(3),358-367","journal-title":"Mol Psychiatry"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"Dorsey E.R.","year":"2018","unstructured":"Dorsey E.R.; Sherer T.; Okun M.S.; Bloem B.R.; The emerging evidence of the parkinson pandemic. J Parkinsons Dis  2018,8(s1),S3-S8","journal-title":"J Parkinsons Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1245049","DOI":"10.1155\/2016\/1245049","volume":"2016","author":"Di Meo S.","year":"2016","unstructured":"Di Meo S.; Reed T.T.; Venditti P.; Victor V.M.; Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev  2016,2016(1),1245049","journal-title":"Oxid Med Cell Longev"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.25634.1","author":"Stoker T.B.","year":"2020","unstructured":"Stoker T.B.; Barker R.A.; Recent developments in the treatment of parkinson's disease. F1000Res  9.2020","journal-title":"F1000Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"806470","DOI":"10.3389\/fphar.2022.806470","volume":"13","author":"Rudrapal M.","year":"2022","unstructured":"Rudrapal M.; Khairnar S.J.; Khan J.; Dukhyil A.B.; Ansari M.A.; Alomary M.N.; Alshabrmi F.M.; Palai S.; Deb P.K.; Devi R.; Dietary polyphenols and their role in oxidative stress-induced human diseases: Insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol  2022,13,806470","journal-title":"Front Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","volume":"2","author":"Pandey K.B.","year":"2009","unstructured":"Pandey K.B.; Rizvi S.I.; Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev  2009,2(5),270-278","journal-title":"Oxid Med Cell Longev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"30723","DOI":"10.18632\/oncotarget.15413","volume":"8","author":"Yang Y.","year":"2017","unstructured":"Yang Y.; Gong X.B.; Huang L.G.; Wang Z.X.; Wan R.Z.; Zhang P.; Zhang Q.Y.; Chen Z.; Zhang B.S.; Diosmetin exerts anti-oxidative, anti-inflammatory and anti-apoptotic effects to protect against endotoxin-induced acute hepatic failure in mice. Oncotarget  2017,8(19),30723-30733","journal-title":"Oncotarget"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.3390\/molecules27238232","volume":"27","author":"W\u00f3jciak M.","year":"2022","unstructured":"W\u00f3jciak M.; Feldo M.; Borowski G.; Kubrak T.; P\u0142achno B.J.; Sowa I.; Antioxidant potential of diosmin and diosmetin against oxidative stress in endothelial cells. Molecules  2022,27(23),8232","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1021\/jf502359x","volume":"62","author":"Liao W.","year":"2014","unstructured":"Liao W.; Ning Z.; Chen L.; Wei Q.; Yuan E.; Yang J.; Ren J.; Intracellular antioxidant detoxifying effects of diosmetin on 2,2-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidative stress through inhibition of reactive oxygen species generation. J Agric Food Chem  2014,62(34),8648-8654","journal-title":"J Agric Food Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5725361","DOI":"10.1155\/2020\/5725361","volume":"2020","author":"Saghaei E.","year":"2020","unstructured":"Saghaei E.; Nasiri B.S.; Safavi P.; Borjian B.Z.; Bijad E.; Diosmetin mitigates cognitive and memory impairment provoked by chronic unpredictable mild stress in mice. Evid Based Complement Alternat Med  2020,2020(1),5725361","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"107046","DOI":"10.1016\/j.intimp.2020.107046","volume":"89","author":"Lee D.H.","year":"2020","unstructured":"Lee D.H.; Park J.K.; Choi J.; Jang H.; Seol J.W.; Anti-inflammatory effects of natural flavonoid diosmetin in IL-4 and LPS-induced macrophage activation and atopic dermatitis model. Int Immunopharmacol  2020,89(Pt A),107046","journal-title":"Int Immunopharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0300-483X(92)90101-J","volume":"73","author":"Villa P.","year":"1992","unstructured":"Villa P.; Cova D.; De Francesco L.; Guaitani A.; Palladini G.; Perego R.; Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. Toxicology  1992,73(2),179-189","journal-title":"Toxicology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"Ibarra-Guti\u00e9rrez M.T.","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez M.T.; Serrano-Garc\u00eda N.; Orozco-Ibarra M.; Rotenone-induced model of parkinson\u2019s disease: Beyond mitochondrial complex I inhibition. Mol Neurobiol  2023,60(4),1929-1948","journal-title":"Mol Neurobiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e7878","DOI":"10.1371\/journal.pone.0007878","volume":"4","author":"Xiong N.","year":"2009","unstructured":"Xiong N.; Huang J.; Zhang Z.; Zhang Z.; Xiong J.; Liu X.; Jia M.; Wang F.; Chen C.; Cao X.; Liang Z.; Sun S.; Lin Z.; Wang T.; Stereotaxical infusion of rotenone: A reliable rodent model for parkinson\u2019s disease. PLoS One  2009,4(11),e7878","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"Cannon J.R.","year":"2009","unstructured":"Cannon J.R.; Tapias V.; Na H.M.; Honick A.S.; Drolet R.E.; Greenamyre J.T.; A highly reproducible rotenone model of parkinson\u2019s disease. Neurobiol Dis  2009,34(2),279-290","journal-title":"Neurobiol Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41598-018-37657-6","volume":"9","author":"Fagotti J.","year":"2019","unstructured":"Fagotti J.; Targa A.D.S.; Rodrigues L.S.; Noseda A.C.D.; Dorieux F.W.C.; Scarante F.F.; Ilkiw J.L.; Louzada F.M.; Chowdhury N.R.; van der Veen D.R.; Middleton B.; Pennings J.L.A.; Swann J.R.; Skene D.J.; Lima M.M.S.; Chronic sleep restriction in the rotenone parkinson\u2019s disease model in rats reveals peripheral early-phase biomarkers. Sci Rep  2019,9(1),1898","journal-title":"Sci Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.1007\/s12035-024-04083-x","volume":"61","author":"Zhang Y.","year":"2024","unstructured":"Zhang Y.; Luo C.; Huang P.; Cheng Y.; Ma Y.; Gao J.; Ding H.; Diosmetin ameliorates hfd-induced cognitive impairments via inhibiting metabolic disorders, mitochondrial dysfunction and neuroinflammation in male SD rats. Mol Neurobiol  2024,61(10),8069-8085","journal-title":"Mol Neurobiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.12659\/MSM.911860","volume":"25","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Jiang Y.; Lu D.; Diosmetin suppresses neuronal apoptosis and inflammation by modulating the phosphoinositide 3-Kinase (PI3K)\/AKT\/Nuclear factor-\u03baB (NF-\u03baB) signaling pathway in a rat model of pneumococcal meningitis. Med Sci Monit  2019,25,2238-2245","journal-title":"Med Sci Monit"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbadis.2018.01.013","volume":"1864","author":"Peng K.","year":"2018","unstructured":"Peng K.; Hu J.; Xiao J.; Dan G.; Yang L.; Ye F.; Zou Z.; Cao J.; Sai Y.; Mitochondrial ATP-sensitive potassium channel regulates mitochondrial dynamics to participate in neurodegeneration of parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis  2018,1864(4)(4 Pt A),1086-1103","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuro.2015.09.009","volume":"52","author":"Zhang S.","year":"2016","unstructured":"Zhang S.; Shao S.Y.; Song X.Y.; Xia C.Y.; Yang Y.N.; Zhang P.C.; Chen N.H.; Protective effects of forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity. Neurotoxicology  2016,52,72-83","journal-title":"Neurotoxicology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","volume":"269","author":"Anusha C.","year":"2017","unstructured":"Anusha C.; Sumathi T.; Joseph L.D.; Protective role of apigenin on rotenone induced rat model of parkinson\u2019s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. Chem Biol Interact  2017,269,67-79","journal-title":"Chem Biol Interact"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/s41598-023-29287-4","volume":"13","author":"Singh R.","year":"2023","unstructured":"Singh R.; Zahra W.; Singh S.S.; Birla H.; Rathore A.S.; Keshri P.K.; Dilnashin H.; Singh S.; Singh S.P.; Oleuropein confers neuroprotection against rotenone-induced model of parkinson\u2019s disease via BDNF\/CREB\/Akt pathway. Sci Rep  2023,13(1),2452","journal-title":"Sci Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/ddr.22077","volume":"84","author":"El-Latif A.M.A.","year":"2023","unstructured":"El-Latif A.M.A.; Rabie M.A.; Sayed R.H.; Fattah M.A.A.E.; Kenawy S.A.; Inosine attenuates rotenone-induced parkinson\u2019s disease in rats by alleviating the imbalance between autophagy and apoptosis. Drug Dev Res  2023,84(6),1159-1174","journal-title":"Drug Dev Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/0269215520956503","volume":"35","author":"Rennie L.","year":"2021","unstructured":"Rennie L.; Opheim A.; Dietrichs E.; L\u00f6fgren N.; Franz\u00e9n E.; Highly challenging balance and gait training for individuals with parkinson\u2019s disease improves pace, rhythm and variability domains of gait \u2013 a secondary analysis from a randomized controlled trial. Clin Rehabil  2021,35(2),200-212","journal-title":"Clin Rehabil"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","volume":"148","author":"Ferro M.M.","year":"2005","unstructured":"Ferro M.M.; Bellissimo M.I.; Anselmo-Franci J.A.; Angellucci M.E.M.; Canteras N.S.; Da Cunha C.; Comparison of bilaterally 6-ohda- and mptp-lesioned rats as models of the early phase of parkinson\u2019s disease: Histological, neurochemical, motor and memory alterations. J Neurosci Methods  2005,148(1),78-87","journal-title":"J Neurosci Methods"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/acsptsci.2c00120","volume":"6","author":"Sharma M.","year":"2023","unstructured":"Sharma M.; Malim F.M.; Goswami A.; Sharma N.; Juvvalapalli S.S.; Chatterjee S.; Kate A.S.; Khairnar A.; Neuroprotective effect of swertiamarin in a rotenone model of parkinson\u2019s disease: Role of neuroinflammation and alpha-synuclein accumulation. ACS Pharmacol Transl Sci  2023,6(1),40-51","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1556\/2060.2020.00036","volume":"107","author":"Thanalakshmi J.","year":"2020","unstructured":"Thanalakshmi J.; Archana R.; Senthilkumar S.; Shakila R.; Pazhanivel N.; Subhashini S.; Role of caloric vestibular stimulation in improvement of motor symptoms and inhibition of neuronal degeneration in rotenone model of parkinson\u2019s disease \u2013 An experimental study. Physiol Int  2020,107(3),390-405","journal-title":"Physiol Int"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-2697(68)90082-1","volume":"25","author":"Srivastava S.K.","year":"1968","unstructured":"Srivastava S.K.; Beutler E.; Accurate measurement of oxidized glutathione content of human, rabbit, and rat red blood cells and tissues. Anal Biochem  1968,25(1),70-76","journal-title":"Anal Biochem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.jchemneu.2020.101890","volume":"112","author":"Balakrishnan R.","year":"2021","unstructured":"Balakrishnan R.; Vijayraja D.; Mohankumar T.; Manimaran D.; Ganesan P.; Choi D.K.; Elangovan N.; Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of parkinson\u2019s disease. J Chem Neuroanat  2021,112,101890","journal-title":"J Chem Neuroanat"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"Ohkawa H.","year":"1979","unstructured":"Ohkawa H.; Ohishi N.; Yagi K.; Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem  1979,95(2),351-358","journal-title":"Anal Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/978-1-0716-3662-6_34","volume":"2761","author":"Srivastava R.","year":"2024","unstructured":"Srivastava R.; Chauhan K.; Sharma R.; Evaluating motor dysfunction and oxidative stress induced by trichloroethylene in wistar rats. Methods Mol Biol  2024,2761,499-510","journal-title":"Methods Mol Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0003-2697(87)90489-1","volume":"161","author":"Beyer W.F.","year":"1987","unstructured":"Beyer W.F.; Fridovich I.; Assaying for superoxide dismutase activity: Some large consequences of minor changes in conditions. Anal Biochem  1987,161(2),559-566","journal-title":"Anal Biochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e22902","DOI":"10.1002\/jbt.22902","volume":"35","author":"Srivastava R.","year":"2021","unstructured":"Srivastava R.; Choudhury P.K.; Dev S.K.; Rathore V.; Neuroprotective effect of \u03b1-pinene self-emulsifying nanoformulation against 6-OHDA induced neurotoxicity on human SH-SY5Y cells and its in vivo validation for anti-parkinson\u2019s effect. J Biochem Mol Toxicol  2021,35(11),e22902","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"Aebi H.","year":"1984","unstructured":"Aebi H.; Catalase in vitro. Methods Enzymol  1984,105,121-126","journal-title":"Methods Enzymol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.bbadis.2016.08.007","volume":"1862","author":"Grings M.","year":"2016","unstructured":"Grings M.; Moura A.P.; Parmeggiani B.; Motta M.M.; Boldrini R.M.; August P.M.; Matt\u00e9 C.; Wyse A.T.S.; Wajner M.; Leipnitz G.; Higher susceptibility of cerebral cortex and striatum to sulfite neurotoxicity in sulfite oxidase-deficient rats. Biochim Biophys Acta Mol Basis Dis  2016,1862(11),2063-2074","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"Lowry O.","year":"1951","unstructured":"Lowry O.; Rosebrough N.; Farr A.L.; Randall R.; Protein measurement with the Folin phenol reagent. J Biol Chem  1951,193(1),265-275","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.6026\/97320630019729","volume":"19","author":"Krishnan M.","year":"2023","unstructured":"Krishnan M.; Prathap L.; Reddy V.; Krishnan M.; Anti oxidative\/neuro-inflammation properties of Withania somnifera root extract on rotenone induced stress in rat brain. Bioinformation  2023,19(6),729-738","journal-title":"Bioinformation"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/molecules28020685","volume":"28","author":"Azimullah S.","year":"2023","unstructured":"Azimullah S.; Jayaraj R.L.; Meeran M.F.N.; Jalal F.Y.; Adem A.; Ojha S.; Beiram R.; Myrcene salvages rotenone-induced loss of dopaminergic neurons by inhibiting oxidative stress, inflammation, apoptosis, and autophagy. Molecules  2023,28(2),685","journal-title":"Molecules"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbagen.2009.11.012","volume":"1800","author":"Li X.","year":"2010","unstructured":"Li X.; Rapedius M.; Baukrowitz T.; Liu G.X.; Srivastava D.K.; Daut J.; Hanley P.J.; 5-Hydroxydecanoate and coenzyme A are inhibitors of native sarcolemmal KATP channels in inside-out patches. Biochim Biophys Acta, Gen Subj  2010,1800(3),385-391","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yjmcc.2005.04.002","volume":"39","author":"Hanley P.","year":"2005","unstructured":"Hanley P.; Daut J.; K channels and preconditioning: A re-examination of the role of mitochondrial K channels and an overview of alternative mechanisms. J Mol Cell Cardiol  2005,39(1),17-50","journal-title":"J Mol Cell Cardiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2024.2341916","author":"Srivastava R.","year":"2024","unstructured":"Srivastava R.; Choudhury P.K.; Dev S.K.; Rathore V.; Alpha-pine self-emulsifying nano formulation attenuates rotenone and trichloroethylene-induced dopaminergic loss. Int J Neurosci  2024,1-18","journal-title":"Int J Neurosci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbr.2014.11.002","volume":"279","author":"Wrangel C.","year":"2015","unstructured":"Wrangel C.; Schwabe K.; John N.; Krauss J.K.; Alam M.; The rotenone-induced rat model of parkinson\u2019s disease: Behavioral and electrophysiological findings. Behav Brain Res  2015,279,52-61","journal-title":"Behav Brain Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41531-023-00561-6","volume":"9","author":"Van Laar A.D.","year":"2023","unstructured":"Van Laar A.D.; Webb K.R.; Keeney M.T.; Van Laar V.S.; Zharikov A.; Burton E.A.; Hastings T.G.; Glajch K.E.; Hirst W.D.; Greenamyre J.T.; Rocha E.M.; Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy. NPJ Parkinsons Dis  2023,9(1),121","journal-title":"NPJ Parkinsons Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jpba.2009.09.012","volume":"51","author":"Campanero M.A.","year":"2010","unstructured":"Campanero M.A.; Escolar M.; Perez G.; Garcia-Quetglas E.; Sadaba B.; Azanza J.R.; Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography\u2013atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study. J Pharm Biomed Anal  2010,51(4),875-881","journal-title":"J Pharm Biomed Anal"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4062\/biomolther.2020.135","volume":"28","author":"Park S.","year":"2020","unstructured":"Park S.; Bong S.K.; Lee J.W.; Park N.J.; Choi Y.; Kim S.M.; Yang M.H.; Kim Y.K.; Kim S.N.; Diosmetin and its glycoside, diosmin, improve atopic dermatitis- like lesions in 2,4-dinitrochlorobenzene-induced murine models. Biomol Ther  2020,28(6),542-548","journal-title":"Biomol Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s11011-017-0060-y","volume":"32","author":"Darbinyan L.V.","year":"2017","unstructured":"Darbinyan L.V.; Hambardzumyan L.E.; Simonyan K.V.; Chavushyan V.A.; Manukyan L.P.; Badalyan S.A.; Khalaji N.; Sarkisian V.H.; Protective effects of curcumin against rotenone-induced rat model of parkinson's disease: In vivo electrophysiological and behavioral study. Metab Brain Dis  2017,32(6),1791-1803","journal-title":"Metab Brain Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"174573","DOI":"10.1016\/j.ejphar.2021.174573","volume":"914","author":"Habib C.N.","year":"2022","unstructured":"Habib C.N.; Mohamed M.R.; Tadros M.G.; Tolba M.F.; Menze E.T.; Masoud S.I.; The potential neuroprotective effect of diosmin in rotenone-induced model of parkinson\u2019s disease in rats. Eur J Pharmacol  2022,914,174573","journal-title":"Eur J Pharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12640-009-9010-8","volume":"15","author":"Rodriguez-Pallares J.","year":"2009","unstructured":"Rodriguez-Pallares J.; Parga J.A.; Joglar B.; Guerra M.J.; Labandeira-Garcia J.L.; The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons. Neurotox Res  2009,15(1),82-95","journal-title":"Neurotox Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuro.2022.09.008","volume":"93","author":"Hong S.W.","year":"2022","unstructured":"Hong S.W.; Teesdale-Spittle P.; Page R.; Truman P.; A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke. Neurotoxicology  2022,93,163-172","journal-title":"Neurotoxicology"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2174\/0109298665333333240909104354","volume":"31","author":"Varshney K.K.","year":"2024","unstructured":"Varshney K.K.; Gupta J.K.; Srivastava R.; Investigating in silico and in vitro therapeutic potential of diosmetin as the anti-parkinson agent. Protein Pept Lett  2024,31(9),714-735","journal-title":"Protein Pept Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"13016","DOI":"10.1021\/acsomega.3c00201","volume":"8","author":"Shahid N.M.","year":"2023","unstructured":"Shahid N.M.; Khan J.A.; Al-Abbasi F.A.; AlGhamdi S.A.; Alghamdi A.M.; Sayyed N.; Gupta G.; Kazmi I.; Protective effect of hirsutidin against rotenone-induced parkinsonism via inhibition of caspase-3\/Interleukins-6 and 1\u03b2. ACS Omega  2023,8(14),13016-13025","journal-title":"ACS Omega"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"12635","DOI":"10.3390\/ijms252312635","volume":"25","author":"S\u00e1nchez-Camacho J.V.","year":"2024","unstructured":"S\u00e1nchez-Camacho J.V.; G\u00f3mez-Chavar\u00edn M.; Galindo-Solano N.; Padilla-Cort\u00e9s P.; Maldonado-Garc\u00eda J.L.; P\u00e9rez-S\u00e1nchez G.; Pav\u00f3n L.; Ram\u00edrez-Santos J.; Rold\u00e1n R.G.; G\u00f3mez-L\u00f3pez M.; Gutierrez-Ospina G.; Non-categorical analyses identify rotenone-induced \u2018parkinsonian\u2019 rats benefiting from nano-emulsified punicic acid (NANO-PSO) in a phenotypically diverse population: Implications for translational neurodegenerative therapies. Int J Mol Sci  2024,25(23),12635","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1871527322666230223150347","volume":"23","author":"Srivastava R.","year":"2024","unstructured":"Srivastava R.; Dilnashin H.; Kapoor D.; Aparna S.; Heidarli E.; Singh S.P.; Jain V.; Role of animal models in parkinson\u2019s disease (PD): What role they play in preclinical translational research. CNS Neurol Disord Drug Targets  2024,23(2),181-202","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12017-019-08590-2","volume":"22","author":"Garabadu D.","year":"2020","unstructured":"Garabadu D.; Agrawal N.; Naringin exhibits neuroprotection against rotenone-induced neurotoxicity in experimental rodents. Neuromolecular Med  2020,22(2),314-330","journal-title":"Neuromolecular Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"911924","DOI":"10.3389\/fnagi.2022.911924","volume":"14","author":"Gao L.","year":"2022","unstructured":"Gao L.; Cao M.; Du G.; Qin X.; Huangqin decoction exerts beneficial effects on rotenone-induced rat model of parkinson\u2019s disease by improving mitochondrial dysfunction and alleviating metabolic abnormality of mitochondria. Front Aging Neurosci  2022,14,911924","journal-title":"Front Aging Neurosci"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665398088250904074136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/246296\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665398088250904074136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:26:37Z","timestamp":1770355597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/246296\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665398088250904074136","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}